DESC (Diploma in Complementary Specialised Studies) Cancerology 11.06
DES (Diploma in Specialised Studies) Oncology option Radiotherapy 11.05
DU (University Diploma) in Radiobiology 06.04
(Faculty of Medicine Paris Xl )
M.Sc. in Medical & Biological Sciences
Cellular pharmacology, pharmacogenetics, pharmacocinetics Certificate Faculty of Medicine Paris Vl 06.02
Differentiation and Oncogenesis Certificate Faculty of Medicine Paris Vl 06.03
Assistantship at Military Hospitals
Chosen Specialism: Oncology option Radiotherapy 09.01
University Capacity in Disaster Medicine 06.97
Faculty of Medicine, Créteil
M.D. (Doctor of Medicine) 06.97
Faculty of Medicine, Claude Bernard Lyon l
DU (University Diploma) in Tropical Medicine 06.96
Faculty of Medicine, Claude Bernard Lyon l

Clinical Experience

Assistant Head of Department since Novembre 2006.
Head of the Radiotherapy Functional Unit since March 2013.
Assistant – Senior Hospital Lecturer:
Oncology-Radiotherapy Department – HIA Val de Grâce – Paris 11.05-10.06
Assistantship at Military Hospitals:

  • May 05 – Oct. 05: Oncology-Radiotherapy Dept.- HIA Val de Grâce- Paris
  • Nov. 04 – Apr. 05: Oncology-Radiotherapy Dept.- HIA Val de Grâce – Paris
  • May 04 – Oct. 04:Radiotherapy Dept. Pr. Housset- Hôpital Européen Georges Pompidou – Paris
  • Nov. 03 – Apr. 04: Oncology-Radiotherapy Dept. – HIA Val-de-Grâce – Paris
  • May 03. – Oct. 03: Oncology-Radiotherapy Dept.- HIA Val-de-Grâce – Paris
  • Nov. 02 – Apr. 03: Radiotherapy Dept. Pr. Cosset- Institut Curie – Paris
  • May 02 – Oct. 02 Haematology Dept. HIA Percy – Clamart
  • Nov. 01 – Apr. 02: Oncology-Radiotherapy Dept. – HIA Val-de-Grâce – Paris
  • Sept.01 –Nov. 01: Infectious Diseases Dept. – HIA Bégin – Saint-Mandé

Chief Medical Officer – General Direction of the National Gendarmerie September 2000 – August 2001
Assistant Medical Officer – Marine Infantry Regiment in the Pacific – New-Caledonia – Plum (New Caledonia) Aug. 1998 – Aug. 2000
Assistant Medical Officer- 5th Engineers Regiment- Versailles Satory November 1997 – July 1998

Sociétés Savantes

Société Française de Radiothérapie – Oncologie


  • · Thèse: Infections à Mycobactéries atypiques chez le patient infecté par le VIH: étude rétrospective sur 37 patients.
  • · Towards an integrated approach to cardiovascular toxicities related to the treatments of breast cancer.
    Tanz R, Magne N, Annede P, Mery B, Jacob J, Bauduceau O, Trone JC, Guichard JB, Meillan N, Kirova Y, Vedrine L, Chargari C.
    Bull Cancer. 2014 Aug 1;101(7-8):730-740
  • · Feasibility of radiation therapy in patients 90years of age and older: a French multicentre analysis.
    Chargari C, Moriceau G, Auberdiac P, Guy JB, Assouline A, Tinquaut F, Falk AT, Eddekkaoui H, Bourmaud A, Coscas Y, Annede P, Rivoirard R, Mery B, Trone JC, Otmezguine Y, Pacaut C, Bauduceau O, Vedrine L, Merrouche Y, Magne N.
    Eur J Cancer. 2014 May;50(8):1490-7
  • · Analysis of feasibility and toxicity of radiotherapy in centenarians.
    Chargari C, Moriceau G, Auberdiac P, Guy JB, Assouline A, Eddekkaoui H, Annede P, Trone JC, Jacob J, Pacaut C, Bauduceau O, Vedrine L, Magne N.
    J Am Geriatr Soc. 2013 Oct;61(10):1833-5.
  • · Neuroendocrine carcinoma of the digestive tract: a literature review].
    Jacob J, Chargari C, Helissey C, Ferrand FR, Ceccaldi B, Le Moulec S, Bauduceau O, Fayolle M, Védrine L.
    Rev Med Interne. 2013 Nov;34(11):700-5.
  • · Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma.
    Moussaid Y, Bonardel G, Jacob J, Métivier D, Gontier E, Bauduceau O, Durand X, Fayolle M, Houlgatte A, Foehrenbach H, Védrine L, Chargari C.
    Cancer Radiother. 2013 Jul-Aug;17(4):259-64.
  • · First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma: data on safety and efficacy.
    Chargari C, Pacaut C, Le Moulec S, Moriceau G, Moussaid Y, Rivoirard R, Dulou R, Jacob J, Guy JB, Bauduceau O, Ceccaldi B, Védrine L, Fournel P, Magné N.
    Anticancer Drugs. 2013 Aug;24(7):736-42
  • · Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights.
    Chargari C, Feuvret L, Bauduceau O, Ricard D, Cuenca X, Delattre JY, Mazeron JJ.
    Cancer Treat Rev. 2012 Dec;38(8):988-95
  • · External beam radiotherapy in the management of spinal metastases: review of current strategies and perspectives for highly conformal irradiation modalities.
    Helissey C, Levy A, Jacob J, Dutertre G, Tardo-Dino PE, Bauduceau O, Vedrine L, Chargari C.
    Discov Med. 2011 Jun;11(61):505-11.
  • · Granulocytic sarcoma in a nonleukemic patient: place of radiotherapy and systemic therapies.
    Chargari C, Jacob J, Bauduceau O, Ferrand FR, De Revel T, Védrine L.
    Case Rep Med. 2011;2011:929161.
  • · Pancreatic metastasis from prostate cancer.
    Jacob J, Chargari C, Bauduceau O, Fayolle M, Ceccaldi B, Prat F, Le Moulec S, Vedrine L.
    Case Rep Med. 2010;2010:826273.
  • · Mechanisms of resistance to molecular targeted therapies in breast cancer: update and future.
    Magné N, Chargari C, Conforti R, Toillon RA, Bauduceau O, Védrine L, Khayat D, Spano JP.
    Bull Cancer. 2010 Mar;97(3):385-95.
  • · Impact of radiotherapy on fertility in female patients.
    Chargari C, Castadot P, Gillion N, Bauduceau O, Védrine L, Haie-Meder C, Spano JP, Magné N.
    Bull Cancer. 2009 Oct;96(10):1005-11.
  • · Positron emission tomography in the management of cervix cancer patients.
    Bonardel G, Chargari C, Gontier E, Bauduceau O, Soret M, Dechaud C, Fayolle M, Foehrenbach H.
    Cancer Radiother. 2009 Oct;13(6-7):490-8.
  • · Radiotherapy of maxillary sinus carcinoma: state of art.
    Chargari C, Bauduceau O, Védrine L, Haen P, Fayolle M, Ceccaldi B, Conessa C, Magné N.
    Cancer Radiother. 2009 Jun;13(3):195-204.
  • · Reapprasial of the role of endocrine therapy in meningioma management.
    Chargari C, Védrine L, Bauduceau O, Le Moulec S, Ceccaldi B, Magné N.
    Endocr Relat Cancer. 2008 Dec;15(4):931-41.
  • · The use of computed tomography in radiotherapy treatment planning for breast cancer. How does conventional radiotherapy planning compare with virtual?
    Bauduceau O, Bollet MA, Pons P, Kirova YM, Fayolle M, Zervoudis S, Campana F.
    J BUON. 2008 Apr-Jun;13(2):245-51.
  • · Prostate cancer and disseminated intravascular coagulation: review of the literature.
    Chargari C, Vedrine L, Bauduceau O, Le Moulec S, Fayolle M, Ceccaldi B, Houlgatte A. Prog Urol.
    2008 Jan;18(1):9-13.
  • · Cancer chemotherapy of the upper aerodigestive tract.
    Védrine L, Chargari C, Le Moulec S, Fayolle M, Ceccaldi B,Bauduceau O.
    Cancer Radiother. 2008 Mar;12(2):110-9.
  • · Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
    Bonnichon A, Vedrine L, Aletti M, Le Moulec S, Borne M, Margery J,Bauduceau O, Fayolle M, Ceccaldi B. Rev Pneumol Clin.
    2007 Dec;63(6):379-83.
  • · Craniopharyngioma.
    Chargari C, Bauduceau O, Le Moulec S, Vedrine L, Ceccaldi B. Rev Prat.
    2007 Oct 31;57(16):1756.
  • · Craniopharyngiomas: role of radiotherapy.
    Chargari C, Bauduceau O, Bauduceau B, Camparo P, Ceccaldi B, Fayolle M, Le Moulec S, Védrine L.
    Bull Cancer. 2007 Nov;94(11):987-94.
  • · Testicular metastasis of prostatic adenocarcinoma: a case report.
    Bauduceau O, Vedrine L, Chargari C, Ceccaldi B, Le Moulec S, Houlgatte A.
    Prog Urol. 2007 Apr;17(2):251-2.
  • · Testicular germ-cell tumour: diagnosis and treatment.
    Houlgatte A, Bauduceau O. Ann Urol (Paris).
    2005 Oct;39(5):159-69.
  • · Comparison of classic simulation and virtual simulation in breast irradiation: prospective study on 14 patients.
    Bauduceau O, Pons P, Campana F, Bollet M, Romero L, Fayolle M.
    Cancer Radiother. 2005 Nov;9(6-7):402-10.
  • · Combined chemotherapy and radiation therapy for intracranial germinomas. The Val-de-Grace hospital experience.
    Védrine L, Bauduceau O, Fayolle M, Le Moulec S, Ceccaldi B.
    Cancer Radiother. 2005 Sep;9(5).
  • · Radiotherapy in stage I testicular seminoma: retrospective study and review of literature].
    Bauduceau O, Souleau B, Le-Moulec S, Houlgatte A, Bernard O.
    Cancer Radiother. 2003 Dec;7(6):386-94.
  • · Advanced nonsmall cell lung cancer: importance of chemotherapy in the control of symptoms.
    Margery J, Le Moulec S, Grassin F, Bauduceau O, Dot JM, Vedrine L, Natali F, Guigay J.
    Bull Cancer. 2003 Oct;90(10):917-8.
  • · Spontaneous hematoma of the iliac psoas muscle in chronic myeloid leukemia. A case report.
    Bauduceau O, De Revel T, Fogelman J, Amadou S, Souleau B, Nedellec G. Ann Med Interne (Paris).
    2003 May;154(3):183-6.
  • · Cylindroma of the trachea, a rate tumor with unusual evolution].
    Bauduceau O, Ceccaldi B, Bernard O, Dourhte LM, Le Moulec S, Hervé R. Presse Med.
    2003 Apr 5;32(13 Pt 1):602.
  • · Initial hypophosphatemia, the only factor associated with acute hepatocellular failure in exercise-induced malignant hyperthermia.
    Garcin JM, Bronstein JA, Bauduceau O, Védrine L, Saissy JM.
    Presse Med. 2001 Dec 8;30(37):1827.
  • · Hepatitis B, C, and E in New Caledonia. Seroepidemiologic study in military recruits.
    Bauduceau O, Berlioz A, Buisson Y.
    Med Trop (Mars). 2000;60(2):167-70.